Genitaler Lichen sclerosus – Diagnostik und Therapie

Felix Neis; Amir Yazdi; Katharina Rall

doi:10.1055/s-0033-1357942

Frauenheilkunde up2date, Table of Contents

Frauenheilkunde up2date 2014; 8(3): 211-225
DOI: 10.1055/s-0033-1357942

Gynäkologische Spezialgebiete und Methoden

Georg Thieme Verlag KG Stuttgart · New York

Genitaler Lichen sclerosus – Diagnostik und Therapie

Authors

Felix Neis
Amir Yazdi
Katharina Rall

Abstract

All articles of this category

Full Text

References

Literatur
1 Cooper SM, Gao XH, Powell JJ et al. Does treatment of vulvar lichen sclerosus influence its prognosis?. Arch Dermatol 2004; 140: 702-706
2 Green C, Guest J, Ngu W. Long-term follow-up of women with genital lichen sclerosus. Menopause Int 2013; [Epub ahead of print]
3 Farrell AM, Marren P, Dean D et al. Lichen sclerosus: evidence that immunological changes occur at all levels of the skin. Br J Dermatol 1999; 140: 1087-1092
4 Harrington CI, Dunsmore IR. An investigation into the incidence of auto-immune disorders in patients with lichen sclerosus and atrophicus. Br J Dermatol 1981; 104: 563-566
5 Birenbaum DL, Young RC. High prevalence of thyroid disease in patients with lichen sclerosus. J Reprod Med 2007; 52: 28-30
6 Cooper SM, Ali I, Baldo M et al. The association of lichen sclerosus and erosive lichen planus of the vulva with autoimmune disease: a case-control study. Arch Dermatol 2008; 144: 1432-1435
7 Marren P, Yell J, Charnock FM et al. The association between lichen sclerosus and antigens of the HLA system. Br J Dermatol 1995; 132: 197-203
8 Wallace HJ. Lichen sclerosus et atrophicus. Transactions of the St Johnʼs Hospital Dermatol Soc 1971; 57: 9-30
9 Goldstein AT, Marinoff SC, Christopher K et al. Prevalence of vulvar lichen sclerosus in a general gynecology practice. J Reprod Med 2005; 50: 477-480
10 Powell JJ, Wojnarowska F. Lichen sclerosus. Lancet 1999; 353: 1777-1783
11 Handfield-Jones SE, Hinde FR, Kennedy CT. Lichen sclerosus et atrophicus in children misdiagnosed as sexual abuse. Br Med J (Clinical research ed) 1987; 294: 1404-1405
12 Pugliese JM, Morey AF, Peterson AC. Lichen sclerosus: review of the literature and current recommendations for management. J Urol 2007; 178: 2268-2276
13 Reyes MC, Cooper K. An update on vulvar intraepithelial neoplasia: terminology and a practical approach to diagnosis. J Clin Pathol 2014; 67: 290-294
14 Ueda Y, Enomoto T, Kimura T et al. Two distinct pathways to development of squamous cell carcinoma of the vulva. J Skin Cancer 2011; 2011: 951250
15 van Seters M, ten Kate FJ, van Beurden M et al. In the absence of (early) invasive carcinoma, vulvar intraepithelial neoplasia associated with lichen sclerosus is mainly of undifferentiated type: new insights in histology and aetiology. J Clin Pathol 2007; 60: 504-509
16 Leibowitch M, Neill S, Pelisse M et al. The epithelial changes associated with squamous cell carcinoma of the vulva: a review of the clinical, histological and viral findings in 78 women. Br J Obstet Gynaecol 1990; 97: 1135-1139
17 Vilmer C, Cavelier-Balloy B, Nogues C et al. Analysis of alterations adjacent to invasive vulvar carcinoma and their relationship with the associated carcinoma: a study of 67 cases. Eur J Gynaecol Oncol 1998; 19: 25-31
18 Chi CC, Kirtschig G, Baldo M et al. Topical interventions for genital lichen sclerosus. Cochrane Database Syst Rev 2011; (12) CD008240
19 Neill SM, Lewis FM, Tatnall FM et al. British Association of Dermatologists guidelines for the management of lichen sclerosus 2010. Br J Dermatol 2010; 163: 672-682
20 Bracco GL, Carli P, Sonni L et al. Clinical and histologic effects of topical treatments of vulval lichen sclerosus. A critical evaluation. J Reprod Med 1993; 38: 37-40
21 Luger T, Paul C. Potential new indications of topical calcineurin inhibitors. Dermatology (Basel, Switzerland) 2007; 215 Suppl 1: 45-54
22 Nissi R, Eriksen H, Risteli J et al. Pimecrolimus cream 1 % in the treatment of lichen sclerosus. Gynecol Obstet Investig 2007; 63: 151-154
23 Hengge UR, Krause W, Hofmann H et al. Multicentre, phase II trial on the safety and efficacy of topical tacrolimus ointment for the treatment of lichen sclerosus. Br J Dermatol 2006; 155: 1021-1028
24 Ormerod AD. Topical tacrolimus and pimecrolimus and the risk of cancer: how much cause for concern?. Br J Dermatol 2005; 153: 701-705
25 Terras S, Gambichler T, Moritz RK et al. UV-A1 phototherapy vs clobetasol propionate, 0.05 %, in the treatment of vulvar lichen sclerosus: a randomized clinical trial. J Am Med Assoc Dermatol 2014;
26 Abramov Y, Elchalal U, Abramov D et al. Surgical treatment of vulvar lichen sclerosus: a review. Obstet Gynecol Surv 1996; 51: 193-199
27 Bradford J, Fischer G. Surgical division of labial adhesions in vulvar lichen sclerosus and lichen planus. J Lower Genital Tract Dis 2013; 17: 48-50
28 Jones RW, Scurry J, Neill S et al. Guidelines for the follow-up of women with vulvar lichen sclerosus in specialist clinics. Am J Obstet Gynecol 2008; 198: 496.e1-496.e3